4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-011662
Chief Executive Officer sold 20,000 shares at an average $46.92 ($938,459)
- Chief Executive Officer acquired 3,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-02-15 | Sale : show line 1 in the form | −2,500 | $45.58 | $113,950 | 260,378 | I |
| 2018-02-15 | Sale : show line 2 in the form | −2,433 | $46.71 | $113,645 | 257,945 | I |
| 2018-02-15 | Sale : show line 3 in the form | −4,767 | $47.56 | $226,719 | 253,178 | I |
| 2018-02-15 | Sale : show line 4 in the form | −300 | $48.25 | $14,475 | 252,878 | I |
| 2018-02-16 | Sale : show line 5 in the form | −3,000 | $45.44 | $136,320 | 249,878 | I |
| 2018-02-16 | Sale : show line 6 in the form | −1,600 | $46.55 | $74,480 | 248,278 | I |
| 2018-02-16 | Sale : show line 7 in the form | −5,100 | $47.91 | $244,341 | 243,178 | I |
| 2018-02-16 | Sale : show line 8 in the form | −300 | $48.43 | $14,529 | 242,878 | I |
| 2018-02-15 | Exercise or conversion : show line 9 in the form | +3,938 | 812,613 | D | ||
| Open-market sales · 20,000 sh · avg $46.92 · $938,459 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-02-15 | Exercise or conversion : show line 10 in the form Restricted Stock Units | −3,938 | 0 | D |
Loading xslF345X03/doc4.xml…